rnabas
noncytopath
replicon
vector
system
base
flaviviru
kunjin
shown
consider
promis
new
vaccin
deliveri
system
describ
test
mice
four
differ
gag
vaccin
deliv
kunjin
replicon
viruslikeparticl
four
vaccin
encod
wild
type
gag
gene
rnaoptimis
gag
gene
codonoptimis
gag
gene
modifi
gagpol
gene
construct
vaccin
behav
quit
differ
induct
effector
memori
central
memori
respons
mediat
protect
respect
insert
stabil
siv
gagpol
vaccin
provid
optim
perform
result
illustr
rnabas
vector
rna
sequenc
antigen
profound
unforeseen
consequ
vaccin
behaviour
number
rnabas
vector
system
use
construct
siv
vaccin
includ
vector
base
neg
strand
rna
virus
posit
strand
rna
virus
sendai
viru
coronaviru
lentivirus
posit
strand
rna
repliconbas
vector
deriv
alphavirus
picornavirus
flavivirus
repliconbas
vector
exploit
abil
viral
nonstructur
protein
amplifi
greatli
cytoplasm
infectedtransfect
cell
replicon
rna
encod
heterolog
protein
viral
nonstructur
protein
result
highlevel
express
antigen
provid
potent
adjuv
activ
via
doublestrand
rna
replic
intermedi
previous
describ
replicon
vector
system
base
kunjin
viru
larg
nonpathogen
flaviviru
found
northern
australia
kunjin
replicon
rna
packag
viruslik
particl
vlp
use
packag
cell
line
express
kunjin
structur
protein
tran
result
vlp
vaccin
capabl
induc
potent
longliv
protect
cell
respons
sever
murin
system
kunjin
replicon
vlp
vaccin
encod
gag
also
shown
induc
cell
immun
compar
seen
immunis
recombin
vaccinia
contrast
alphaviru
repliconinfect
cell
kunjin
repliconinfect
cell
show
overt
cytopath
effect
doubl
strand
rnainduc
danger
signal
antigen
product
maintain
extend
period
ii
produc
replicationcompet
virus
via
recombin
vlp
manufactur
recombin
flaviviru
system
appear
extrem
low
evalu
siv
vaccin
nonhuman
primat
prove
invalu
endur
model
system
test
new
concept
hiv
vaccin
develop
siv
hiv
subunit
vaccin
encod
gag
gag
protein
believ
import
target
protect
cellular
immun
herein
describ
construct
immunogen
four
siv
gag
pol
kunjin
replicon
vlp
vaccin
first
encod
siv
gag
use
wildtyp
nucleic
acid
sequenc
wt
second
encod
siv
gag
use
rnaoptimis
nucleic
acid
sequenc
dx
hiv
siv
gag
contain
rna
inhibitori
sequenc
in
element
shown
act
sever
level
inhibit
gag
express
primarili
via
nuclear
retent
rna
absenc
rev
protein
rnaoptimis
strategi
remov
in
element
chang
codon
usag
result
signific
increas
protein
express
dnabas
express
vector
rnaoptimis
siv
gag
vaccin
use
number
monkey
trial
inhibit
nuclear
export
gag
rna
in
sequenc
unlik
issu
exclus
cytoplasm
kunjin
replicon
rna
howev
in
element
also
report
reduc
rna
stabil
translat
third
siv
gag
kunjin
replicon
vlp
vaccin
encod
human
codonoptimis
siv
gag
gene
opt
codon
optimis
use
extens
improv
recombin
antigen
express
number
system
process
involv
alter
codon
usag
one
commonli
util
given
speci
fourth
vaccin
encod
wildtyp
matrix
capsid
gaglink
infram
revers
transcriptas
pol
gagpol
approach
describ
previous
hiv
gag
remov
gag
gene
sequenc
encod
protein
potenti
immunosuppress
properti
whilst
retain
sequenc
frequent
recognis
cell
although
four
vaccin
express
gag
protein
compar
level
behav
quit
differ
term
immunogen
protect
insert
stabil
rnabas
kunjin
replicon
vector
use
construct
wt
dx
opt
vaccin
use
construct
gagpol
vaccin
two
rnabas
kunjin
replicon
vector
except
two
copi
foot
mous
viru
autoproteas
one
upstream
mlui
replac
ubiquitin
gene
anoth
one
downstream
snabi
clone
site
kunjin
siv
gag
wt
construct
encod
siv
gag
subclon
catalogu
nih
aid
research
refer
reagent
program
germantown
md
usa
use
asci
site
kunjin
siv
gag
dx
construct
gener
subclon
rnaoptimis
siv
gag
dx
pfbsivgag
dx
cte
neo
use
ascisnabi
site
kunjin
sivgag
opt
construct
use
ascisnabi
site
catalogu
nih
aid
research
refer
reagent
program
encod
human
codonoptimis
gag
kunjin
gagpol
vaccin
construct
separ
pcramplifi
matrix
nucleocapsid
nc
revers
transcriptas
rt
gene
plasmid
nih
aid
research
refer
reagent
program
join
sacii
fragment
clone
mlu
snab
site
vector
construct
gag
vaccin
describ
previous
express
vector
gag
construct
use
studyencod
alanin
place
initi
glycin
gag
kunjin
replicon
rna
transcrib
vitro
use
rna
polymeras
electropor
tetkuncprm
bhk
packag
cell
describ
previous
briefli
rna
g
electropor
packag
cell
suspens
cell
seed
dish
incub
c
day
cultur
fluid
collect
day
titr
infecti
vlp
infecti
unit
iu
determin
infect
vero
cell
serial
dilut
cultur
fluid
h
postinfect
cell
fix
methanolaceton
vv
analys
immunofluoresc
antibodi
stain
use
monoclon
antibodi
antisiv
gag
monoclon
antibodi
catalogu
nih
aid
research
refer
reagent
program
number
posit
cell
count
use
zeiss
axiophot
fluoresc
microscop
carl
zeiss
microimag
gmbh
berlin
germani
vero
bhk
cell
infect
vlp
moi
electropor
g
kunjin
siv
gag
rna
construct
cultur
day
dish
cell
lyse
ripa
buffer
cell
debri
remov
centrifug
protein
concentr
sampl
determin
use
biorad
protein
assay
biorad
regent
park
nsw
australia
fifteen
microgram
total
cell
protein
separ
gel
sdspage
transfer
onto
hybondp
membran
amershampharmacia
biotech
uk
use
mini
tran
blot
transfer
tank
biorad
regent
park
nsw
australia
c
histag
recombin
siv
clade
b
gag
protein
express
plasmid
merck
pti
ltd
vic
australia
control
escherichia
coli
purifi
use
niagaros
column
gag
protein
detect
use
vero
cell
transfect
kunjin
siv
gag
vlp
moi
cultur
h
total
rna
collect
use
trizol
reagent
invitrogen
superscript
iii
revers
transcriptas
invitrogen
use
produc
cdna
pcr
primer
bind
kunjin
replicon
vector
backbon
use
amplifi
fragment
cdna
use
dynazym
ext
finnzym
diagnost
espoo
finland
forward
primer
ggctgtcaatatgctaaaacg
revers
primer
tctttctctccgtgaacgtgcat
femal
balbc
mice
week
suppli
anim
resourc
centr
perth
western
australia
mice
vaccin
kunjin
replicon
siv
gag
vlp
vaccin
wt
opt
dx
gagpol
kunjin
gag
vlp
vaccin
control
vlp
dilut
rpmi
iu
inject
intraperiton
ip
rout
final
volum
l
interferon
elispot
assay
conduct
use
overlap
peptid
span
entir
subtyp
b
gag
protein
respect
catalogu
respect
nih
aid
research
refer
reagent
program
peptid
divid
six
pool
total
final
concentr
peptid
mix
pool
gml
kunjinspecif
respons
direct
gyistrvel
use
auspep
parkvil
victoria
australia
ex
vivo
elispot
assay
conduct
describ
previous
except
multiscreenip
hydrophob
pvdf
membran
microtitr
plate
millipor
australia
ltd
north
ryde
australia
iuml
kindli
provid
cetu
corp
emeryvil
ca
usa
use
highest
cell
concentr
cellswel
triplic
follow
four
doubl
dilut
spot
count
use
ks
elispot
reader
carl
zeiss
vision
gmbh
hallbergmoo
germani
mean
background
spot
well
without
peptid
subtract
mean
number
spot
obtain
well
peptid
cultur
elispot
assay
perform
use
splenocyt
cultur
vitro
day
well
plate
cellswel
ml
medium
singl
pool
entir
overlap
gag
peptid
gml
peptid
pool
gyistrvel
gml
cultur
splenocyt
presenc
gml
siv
peptid
pool
result
excess
respons
detect
micedata
shown
day
ml
medium
ad
well
day
cell
use
elispot
assay
describ
start
cell
per
well
follow
four
doubl
dilut
group
n
compar
use
total
peptid
respons
mous
nonparametr
median
test
mont
carlo
signific
given
spp
window
version
spss
inc
chicago
il
usa
plasmid
encod
egfpsiv
gag
dx
fusion
protein
gener
subclon
human
rnaoptimis
siv
gag
dx
plasmid
pcmvsivgagdx
provid
dr
b
felber
xhoiecori
site
pegfp
plasmid
catalogu
bd
bioscienc
franklin
lake
nj
usa
gener
pegfp
sivgagdx
plasmid
use
transfect
balbcderiv
murin
lymphoblast
leukemia
cell
atcc
use
genejamm
transfect
reagent
stratagen
la
jolla
ca
usa
cell
cultur
h
sort
use
moflo
highperform
cell
sorter
dako
glostrup
denmark
high
egfp
express
sort
cell
cultur
medium
contain
gml
week
sort
high
egfp
express
procedur
repeat
eight
time
point
express
stabilis
cell
express
egfp
assess
fac
week
cultur
select
express
egfpsiv
gag
dx
fusion
protein
also
confirm
western
blot
use
antisiv
gag
antiegfp
antibodi
molecular
probe
leiden
netherland
unabl
gener
gagexpress
line
use
macrophag
cell
group
balbc
mice
vaccin
twice
separ
week
iu
four
differ
vlp
encod
siv
gag
control
vlp
rpmi
ip
rout
approxim
month
last
immunis
mice
challeng
cell
cellsmous
back
subcutan
rout
hair
around
inject
site
remov
electr
shaver
prior
challeng
facilit
inject
measur
tumour
tumour
size
measur
three
time
week
mice
sacrif
tumour
area
reach
mm
differ
kaplanmei
surviv
curv
calcul
use
logrank
test
spss
window
four
differ
kunjin
replicon
vlp
vaccin
encod
siv
gag
construct
sivgag
wt
wt
siv
gag
dx
dx
siv
gag
opt
opt
siv
gagpol
gagpol
fig
wt
encod
fulllength
wildtyp
siv
gag
dx
opt
encod
rnaand
codonoptimis
version
siv
gag
gene
respect
gagpol
encod
wild
type
matrix
capsid
gag
connect
infram
revers
transcriptas
pol
gag
construct
encod
wildtyp
hiv
gag
use
posit
control
see
vector
backbon
shown
fig
vitro
transcrib
rna
deriv
kunjin
replicon
dna
construct
use
manufactur
vlp
packag
cell
vlp
vaccin
use
infect
vero
cell
vitro
western
blot
experi
use
antisiv
gag
antibodi
illustr
vaccin
express
protein
expect
molecular
weight
fig
similar
data
produc
kunjin
rna
rather
vlp
use
transfect
bhk
cell
fig
indic
major
differ
express
monkey
rodent
cell
experi
major
improv
protein
express
level
seen
dx
opt
vaccin
despit
rnaand
codon
optimis
vitro
siv
gag
particl
format
observ
electron
microscopi
vaccinedata
shown
lysat
siv
gag
gag
vlpinfect
cell
initi
compar
side
side
western
analys
use
antibodi
surpris
find
express
siv
gag
appear
substanti
lower
fig
emerg
howev
antibodi
recognis
siv
gag
protein
much
less
effect
gag
protein
fig
siv
gag
express
thu
probabl
realiti
substanti
lower
hiv
gag
express
kunjin
replicon
system
extens
analysi
panel
antibodi
use
detect
siv
gag
protein
also
reveal
hitherto
unpublish
differ
reactiv
gag
protein
differ
siv
strain
use
differ
techniqu
shown
data
tabl
ad
publish
inform
complet
inform
hope
allow
other
identifi
easili
appropri
antibodi
futur
siv
gag
studi
compar
immunogen
kunjin
siv
gag
vaccin
construct
balbc
mice
immunis
twice
iu
four
vlp
vaccin
iu
repres
titr
vlp
express
gag
see
tabl
mous
receiv
number
kunjin
vlp
encod
gag
two
neg
control
group
includ
account
nonspecif
respons
one
group
receiv
vaccin
control
second
vaccin
vlp
encod
gag
control
vlp
immunis
kunjin
vlp
encod
gag
also
includ
ten
week
last
immunis
splenocyt
assay
ex
vivo
cultur
elispot
assay
use
six
pool
overlap
peptid
span
entir
siv
gag
protein
case
hiv
gag
immunis
mice
hiv
gag
protein
use
peptid
pool
cover
gag
measur
cell
respons
mice
describ
previous
ex
vivo
elispot
assay
measur
immedi
effector
function
thu
tend
measur
effector
memori
cell
activ
wherea
cultur
elispot
assay
measur
abil
cell
replic
form
effector
cell
thu
repres
measur
central
memori
cell
activ
ex
vivo
elispot
assay
illustr
respons
induc
wt
vaccin
significantli
higher
control
vlp
p
fig
dx
induc
respons
approach
signific
control
vlp
p
opt
gagpol
hiv
gag
vaccin
induc
respons
significantli
higher
control
vlp
p
respect
fig
opt
gagpol
vaccineinduc
respons
compar
induc
kunjin
gag
vlp
vaccin
test
condit
fig
use
cultur
elispot
assay
wt
opt
fail
produc
signific
respons
control
fig
gagpol
con
struct
induc
significantli
higher
respons
wt
p
wherea
dx
due
high
mous
mous
variat
group
rang
spot
reach
signific
wt
use
median
test
although
reach
asymptot
signific
use
mannwhitney
test
p
dx
gagpol
vaccin
also
induc
respons
compar
induc
gag
vlp
vaccin
fig
pool
domin
gag
respons
fig
pool
contain
immunodomin
amqmlketi
epitop
spauld
et
al
identifi
region
dengu
viru
repres
domin
cell
epitop
confirm
homolog
region
gyistrvel
kunjin
viru
contain
substitut
l
last
amino
acid
also
repres
domin
cell
epitop
kunjin
replicon
vaccin
data
shown
analys
level
antivector
cell
respons
differ
vaccin
shown
fig
b
elispot
assay
use
gyistrvel
peptid
epitop
gml
undertaken
ex
vivo
elispot
analysi
show
respons
rang
splenocyt
fig
cultur
elispot
analysi
show
rang
splenocyt
vector
except
dx
gave
larg
mean
respons
excess
splenocyt
fig
larg
respons
dx
might
due
larg
number
vlp
express
gag
present
dx
prepar
tabl
result
illustr
flaviviru
repliconbas
vector
like
vector
system
also
induc
cell
respons
specif
vector
protein
other
note
flaviviru
vlp
lose
express
certain
insert
gene
investig
extent
differ
siv
gag
vlp
vaccin
suffer
problem
vero
cell
infect
vlp
duallabel
antikunjin
antigag
antibodi
wt
gagpol
major
vlpinfect
cell
express
gag
howev
dx
opt
posit
cell
respect
also
express
gag
tabl
hiv
gag
vlp
valu
data
shown
dx
opt
construct
contain
rnaand
codonoptimis
gene
perhap
suggest
alter
code
sequenc
somehow
reduc
stabil
insert
gene
kunjin
replicon
construct
vitro
transcrib
rna
use
transfect
packag
cell
contain
detect
truncat
replicon
rna
speci
fig
indic
insert
delet
event
like
occur
vlp
manufactur
gene
delet
event
flaviviru
vector
extens
studi
gain
insight
process
rna
wt
dx
vlpinfect
cell
analys
rtpcr
use
primer
flank
siv
gag
gene
insert
fulllength
gene
visibl
bp
shorter
pcr
product
evid
wt
dx
infect
cell
gene
delet
wt
dx
appear
differ
dx
show
major
band
bp
fig
lane
band
size
also
observ
sampl
optinfect
cell
data
shown
bp
fragment
actual
smaller
obtain
empti
vector
fig
lane
suggest
least
one
end
delet
must
lie
within
ubiquitin
clone
site
fmdv
proteas
region
see
fig
sequenc
bp
fragment
dx
illustr
delet
occur
nucleotid
past
end
nucleotid
ub
sequenc
nucleotid
past
end
nucleotid
sequenc
fig
obviou
homolog
sequenc
either
side
insert
delet
site
would
suggest
strand
switch
homolog
recombin
event
vlp
vaccin
titr
vero
cell
cultur
h
ifa
perform
use
antisiv
gag
monoclon
antibodi
iu
titr
calcul
antibodi
ratio
titr
repres
percentag
gag
titr
recombin
vaccinia
virus
encod
antigen
use
extens
surrog
viral
challeng
model
mice
assess
protect
immun
respons
induc
differ
vaccin
determin
whether
two
recombin
vaccinia
virus
one
encod
siv
mne
gagpol
kind
gift
dr
shiulok
hu
univers
washington
seattl
wa
siv
gag
centr
aid
reagent
nation
institut
biolog
standard
control
uk
could
use
assay
unfortun
although
grew
well
vitro
vaccinia
virus
replic
poorli
mice
follow
ip
intranas
intraven
inocul
pfu
viru
data
shown
make
unsuit
assay
vaccinia
viru
encod
gag
run
parallel
replic
effici
describ
previous
vaccinia
encod
gag
report
replic
mice
howev
vaccinia
viru
made
publicli
avail
reason
better
replic
mice
unclear
develop
altern
challeng
assay
gener
lymphoblast
leukemia
line
stabli
express
siv
gag
dx
fuse
egfp
cell
western
blot
illustr
cell
express
gagegfp
fusion
protein
expect
molecular
weight
kda
fig
cell
use
challeng
anim
month
vaccin
differ
siv
vlp
vaccin
opt
gagpol
dx
vaccin
provid
significantli
better
protect
control
wt
vaccin
logrank
test
p
fig
opt
vaccin
also
provid
significantli
better
protect
dx
p
comparison
show
signific
differ
fig
mean
tumour
growth
curv
experi
shown
fig
percentag
mice
surviv
challeng
cell
wt
dx
gagpol
opt
respect
fig
correl
well
mean
ex
vivo
elispot
data
shown
fig
splenocyt
respect
r
similar
comparison
cultur
elispot
data
fig
fail
show
correl
r
suggest
effector
memori
rather
central
memori
cell
activ
major
role
mediat
protect
model
vaccin
seri
pathogen
includ
hivsiv
develop
use
number
rnabas
viral
vector
system
describ
behaviour
four
differ
kunjin
replicon
vlp
vaccin
encod
siv
gag
show
gagpol
vaccin
induc
good
level
effector
memori
central
memori
cell
respons
week
postvaccin
compar
induc
previous
describ
gag
kunjin
replicon
vlp
vaccin
ii
show
good
level
protect
challeng
cell
express
siv
gag
month
postvaccin
iii
display
high
level
insert
stabil
wt
dx
vaccin
induc
poor
effector
memori
respons
provid
poor
protect
activ
opt
dx
show
high
level
insert
delet
potenti
genet
instabl
mani
recombin
viral
vector
well
describ
rang
larg
vectorspecif
strategi
adopt
limit
problem
kunjin
replicon
system
delet
insert
gene
appear
occur
packag
cell
vlp
manufactur
construct
low
insert
stabil
proport
vlp
without
insert
increas
time
rna
transfect
packag
line
vlp
harvest
extend
appropri
reduct
immunis
twice
iu
indic
kunjin
vlp
vaccin
two
control
group
one
receiv
iu
control
vlp
encod
irrelev
antigen
control
vlp
receiv
vaccin
control
ten
week
second
immunis
mice
sacrif
splenocyt
assay
gagspecif
cell
respons
ex
vivo
elispot
use
six
pool
overlap
peptid
span
either
siv
gag
protein
siv
gag
vaccin
anim
gag
protein
gag
vaccin
anim
error
bar
illustr
variat
respons
pool
b
measur
gagspecif
respons
cultur
elispot
assay
splenocyt
anim
describ
also
cultur
day
pool
siv
hiv
gag
peptid
prior
elispot
assay
c
measur
respons
ex
vivo
elispot
assay
splenocyt
anim
describ
also
use
ex
vivo
elispot
assay
use
cell
peptid
epitop
gyistrvel
measur
respons
cultur
elispot
assay
splenocyt
anim
describ
cultur
day
gyistrvel
peptid
prior
elispot
assay
use
peptid
time
period
result
vlp
prepar
substanti
fewer
empti
vlp
unpublish
observ
observ
parallel
obtain
west
nile
replicon
vlp
insert
delet
also
rapidli
select
serial
passag
vlp
packag
cell
line
contrast
gener
antibiot
select
sever
cell
line
stabli
transfect
recombin
kunjin
replicon
vector
could
extens
passag
without
loss
report
gene
insert
suggest
insert
delet
may
rare
cell
transfect
one
might
specul
insert
delet
associ
cellular
stress
lead
cytopath
effect
observ
packag
cell
vlp
manufactur
due
high
level
structur
protein
express
conceiv
stress
cell
replicon
rna
may
gain
access
nuclear
rna
splice
machineri
rna
splice
well
known
influenc
complex
rna
structur
interact
distant
rna
sequenc
abl
regul
splice
event
dx
opt
vaccin
would
suscept
insert
delet
remain
unclear
may
associ
loss
nativ
rna
structur
dx
gene
engin
allow
revindepend
express
dnabas
vector
system
howev
provid
signific
improv
antigen
express
neg
influenc
siv
gag
in
sequenc
rna
stabil
translat
therefor
appear
signific
system
success
express
wildtyp
siv
gag
vector
system
mrna
gener
cytoplasm
eg
alphaviru
replicon
vaccinia
also
support
view
major
influenc
in
element
rna
export
human
codonoptimis
kunjin
opt
construct
result
significantli
higher
gag
express
vero
monkey
bhk
hamster
cell
suggest
trna
particularli
limit
repliconbas
express
system
test
vitro
opt
gagpol
might
provid
slightli
improv
effector
memori
respons
wt
opt
induc
poor
central
memori
respons
deliv
kunjin
replicon
vlp
remain
unclear
like
reflect
multipl
factor
includ
number
empti
vlp
vaccin
inocula
level
length
antigen
express
vivo
level
danger
signal
induc
replic
replicon
rna
better
memori
respons
induc
gagpol
vaccin
may
due
remov
potenti
immunosuppress
gagencod
protein
alphaviru
replicon
siv
vaccin
region
delet
also
show
improv
longev
cell
respons
fulllength
gag
construct
high
albeit
variabl
central
memori
respons
induc
dx
may
aris
increas
level
produc
result
larg
number
empti
vlp
compromis
vlp
inocula
vaccin
prepar
tabl
gag
challeng
model
fig
repres
new
model
test
effect
cell
induct
siv
gag
vaccin
model
like
repres
measur
siv
gagspecif
cell
activ
reject
tumour
previous
shown
cell
depend
protect
model
also
correl
well
magnitud
ex
vivo
elispot
effector
memori
respons
rather
cultur
elispot
central
memori
respons
induc
kunjin
siv
vaccin
might
expect
sinc
tumour
gener
poor
stimul
differenti
central
memori
cell
effector
prophylact
protect
would
reli
effector
memori
cell
rel
import
effector
memori
andor
central
memori
cell
prophylact
protect
extens
studi
evid
suggest
central
memori
cell
import
effector
memori
cell
wherea
other
argu
effector
activ
earli
infect
effector
mem
group
mice
n
immunis
twice
indic
vlp
vaccin
challeng
month
later
cell
anim
euthanas
tumour
reach
mm
c
mean
growth
curv
tumour
experi
anim
euthans
valu
mm
includ
anim
mean
subsequ
time
point
ori
cell
would
activ
import
protect
slow
progress
aid
summari
describ
kunjin
replicon
siv
gagpol
vlp
vaccin
show
high
insert
stabil
good
induct
effector
central
memori
respons
good
protect
model
challeng
siv
gag
vaccin
fail
one
criteria
illustr
antigen
construct
insert
nucleotid
sequenc
unforeseen
consequ
perform
rna
replicon
vector
aid
research
refer
reagent
program
divis
aid
niaid
nih
dr
ronald
desrosi
dr
stephen
dewhurst
monoclon
antibodi
hiv
dr
jonathan
allan
sivmac
monoclon
antibodi
dr
niel
pedersen
con
b
gag
peptidescomplet
set
sivmac
gag
peptidescomplet
set
gag
